Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Artikel: DFG Deutsche Nationallizenzen  (2)
  • 27.70.+q  (1)
  • Atypical antipsychotic  (1)
  • 1
    ISSN: 1432-2072
    Schlagwort(e): Key words PET ; Pharmacokinetics ; Dopamine D2 receptor ; Serotonin 5HT2 receptor ; Atypical antipsychotic ; Quetiapine
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract Quetiapine (Seroquel) is a novel antipsychotic with an atypical profile in animal models and a relatively short plasma half-life of 2.5–5 h. In the present study, we used PET to compare the time course of blockade of dopamine D2 and serotonin 5HT2 receptors of quetiapine using C11-raclopride and C11-N-methyl-spiperone as ligands, parallel to monitoring plasma drug concentrations. It was an open study in 11 schizophrenic men using a fixed dose of 450 mg quetiapine. Eight men completed the 29 days treatment, followed by four PET scans performed over a 26-h period after withdrawal of the compound. Quetiapine was shown to bind to dopamine D2 receptors in striatum and 2 h (tmax) after the last dose, 44% receptor occupancy was calculated. After 26 h it had dropped to the same level as was found in untreated healthy volunteers. Serotonin 5HT2 receptor blockade in the frontal cortex was 72% after 2 h, which declined to 50% after 26 h. The terminal plasma half-life of quetiapine was 5.3 h. Clinically, our eight patients had good antipsychotic effect without any extrapyramidal side-effects. Our data shows that quetiapine has a relatively low affinity for dopamine D2 receptors, with an occupancy half-life (10 h), which was about twice as long as that for plasma. A more prolonged blockade of the serotonin 5HT2 receptors was found in the frontal cortex, with receptor occupancy half-life of 27 h. Compared to clozapine, as demonstrated in other studies, quetiapine has much the same ratio of D2/5HT2 occupancy. This could suggest that the combination of D2/5HT2 receptor blockade contributes to the antipsychotic effect and a low incidence of EPS seen with quetiapine in comparative phase three trials. Our results also confirm the clinical data that quetiapine can be administered twice daily.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    ISSN: 1434-601X
    Schlagwort(e): 21.10.−K ; 21.60.−n ; 25.70.−z ; 27.70.+q
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Physik
    Notizen: Abstract The strongly shape driving πh9/2[541]l/2− configuration with α=+1/2 exhibits some anomalous, and so far unexplained, features concerning the crossing frequency, ħωc, the aligned angular momentum, ix, and interaction strength, at the alignment of the first pair of i13/2 quasineutrons in several odd-Z rare earth-nuclei. The h9/2[541]1/2− and h11/2[523]7/2− bands have been studied in the stably deformed rare-earth nucleus163Tm to investigate these features. A difference in band crossing frequency of ∼ 80 keV between the two bands is found. Rotational bands built on these two configurations have been found to cross in the spin range I=25/2–29/2 ħ. Theγ-decay pattern between the two bands is established in the crossing region and analysed in terms of a moderate shape difference between them. A theoretical estimate of the size of the interaction strength between the two bands is presented and compared to the experimental value. The observed band structure in163Tm is very similar to that of167Lu which has 2 protons and 2 neutrons in addition. This observation is discussed in relation to the similarity of the yrast bands of the two even-even “core” nuclei162Er and166Yb, for which theγ-transition energies are identical within ∼0.2 keV below the vi13/2 crossing.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...